{"pmid":32427393,"title":"Telomeres and COVID-19.","text":["Telomeres and COVID-19.","The medical, public health, and scientific communities are grappling with monumental imperatives to contain COVID-19, develop effective vaccines, identify efficacious treatments for the infection and its complications, and find biomarkers that detect patients at risk of severe disease. The focus of this communication is on a potential biomarker, short telomere length (TL), that might serve to identify patients more likely to die from the SARS-CoV-2 infection, regardless of age. The common thread linking these patients is lymphopenia, which largely reflects a decline in the numbers of CD4/CD8 T cells but not B cells. These findings are consistent with data that lymphocyte TL dynamics impose a limit on T-cell proliferation. They suggest that T-cell lymphopoiesis might stall in individuals with short TL who are infected with SARS-CoV-2.","FASEB J","Aviv, Abraham","32427393"],"abstract":["The medical, public health, and scientific communities are grappling with monumental imperatives to contain COVID-19, develop effective vaccines, identify efficacious treatments for the infection and its complications, and find biomarkers that detect patients at risk of severe disease. The focus of this communication is on a potential biomarker, short telomere length (TL), that might serve to identify patients more likely to die from the SARS-CoV-2 infection, regardless of age. The common thread linking these patients is lymphopenia, which largely reflects a decline in the numbers of CD4/CD8 T cells but not B cells. These findings are consistent with data that lymphocyte TL dynamics impose a limit on T-cell proliferation. They suggest that T-cell lymphopoiesis might stall in individuals with short TL who are infected with SARS-CoV-2."],"journal":"FASEB J","authors":["Aviv, Abraham"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32427393","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1096/fj.202001025","keywords":["covid-19","t cells","telomeres","lymphopenia"],"topics":["Diagnosis","Mechanism","Treatment"],"weight":1,"_version_":1667352728731385858,"score":9.490897,"similar":[{"pmid":32473127,"title":"Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.","text":["Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.","Understanding adaptive immunity to SARS-CoV-2 is important for vaccine development, interpreting coronavirus disease 2019 (COVID-19) pathogenesis, and calibration of pandemic control measures. Using HLA class I and II predicted peptide \"megapools,\" circulating SARS-CoV-2-specific CD8(+) and CD4(+) T cells were identified in approximately 70% and 100% of COVID-19 convalescent patients, respectively. CD4(+) T cell responses to spike, the main target of most vaccine efforts, were robust and correlated with the magnitude of the anti-SARS-CoV-2 IgG and IgA titers. The M, spike, and N proteins each accounted for 11%-27% of the total CD4(+) response, with additional responses commonly targeting nsp3, nsp4, ORF3a, and ORF8, among others. For CD8(+) T cells, spike and M were recognized, with at least eight SARS-CoV-2 ORFs targeted. Importantly, we detected SARS-CoV-2-reactive CD4(+) T cells in approximately 40%-60% of unexposed individuals, suggesting cross-reactive T cell recognition between circulating \"common cold\" coronaviruses and SARS-CoV-2.","Cell","Grifoni, Alba","Weiskopf, Daniela","Ramirez, Sydney I","Mateus, Jose","Dan, Jennifer M","Moderbacher, Carolyn Rydyznski","Rawlings, Stephen A","Sutherland, Aaron","Premkumar, Lakshmanane","Jadi, Ramesh S","Marrama, Daniel","de Silva, Aravinda M","Frazier, April","Carlin, Aaron F","Greenbaum, Jason A","Peters, Bjoern","Krammer, Florian","Smith, Davey M","Crotty, Shane","Sette, Alessandro","32473127"],"abstract":["Understanding adaptive immunity to SARS-CoV-2 is important for vaccine development, interpreting coronavirus disease 2019 (COVID-19) pathogenesis, and calibration of pandemic control measures. Using HLA class I and II predicted peptide \"megapools,\" circulating SARS-CoV-2-specific CD8(+) and CD4(+) T cells were identified in approximately 70% and 100% of COVID-19 convalescent patients, respectively. CD4(+) T cell responses to spike, the main target of most vaccine efforts, were robust and correlated with the magnitude of the anti-SARS-CoV-2 IgG and IgA titers. The M, spike, and N proteins each accounted for 11%-27% of the total CD4(+) response, with additional responses commonly targeting nsp3, nsp4, ORF3a, and ORF8, among others. For CD8(+) T cells, spike and M were recognized, with at least eight SARS-CoV-2 ORFs targeted. Importantly, we detected SARS-CoV-2-reactive CD4(+) T cells in approximately 40%-60% of unexposed individuals, suggesting cross-reactive T cell recognition between circulating \"common cold\" coronaviruses and SARS-CoV-2."],"journal":"Cell","authors":["Grifoni, Alba","Weiskopf, Daniela","Ramirez, Sydney I","Mateus, Jose","Dan, Jennifer M","Moderbacher, Carolyn Rydyznski","Rawlings, Stephen A","Sutherland, Aaron","Premkumar, Lakshmanane","Jadi, Ramesh S","Marrama, Daniel","de Silva, Aravinda M","Frazier, April","Carlin, Aaron F","Greenbaum, Jason A","Peters, Bjoern","Krammer, Florian","Smith, Davey M","Crotty, Shane","Sette, Alessandro"],"date":"2020-05-31T11:00:00Z","year":2020,"_id":"32473127","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1016/j.cell.2020.05.015","keywords":["cd4","cd8","covid-19","sars-cov-2","t cells","coronavirus","cross-reactivity","epitopes"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668255193293127681,"score":226.29274},{"pmid":32402928,"title":"Lockdown for CoViD-2019 in Milan: What are the effects on air quality?","text":["Lockdown for CoViD-2019 in Milan: What are the effects on air quality?","Based on the rapid spread of the CoViD-2019, a lockdown was declared in the whole Northern Italy by the Government. The application of increasingly rigorous containment measures allowed to reduce the impact of the CoViD-2019 pandemic on the Italian National Health System but at the same time these restriction measures gave also the opportunity to assess the effect of anthropogenic activities on air pollutants in an unprecedented way. This paper aims to study the impact of the partial and total lockdown (PL and TL, respectively) on air quality in the Metropolitan City of Milan. As results, the severe limitation of people movements following the PL and the subsequent TL determined a significant reduction of pollutants concentration mainly due to vehicular traffic (PM10, PM2.5, BC, benzene, CO, and NOx). The lockdown led to an appreciable drop in SO2 only in the city of Milan while it remained unchanged in the adjacent areas. Despite the significant decrease in NO2 in the TL, the O3 exhibited a significant increase, probably, due to the minor NO concentration. In Milan and SaA the increase was more accentuated, probably, due to the higher average concentrations of benzene in Milan than the adjacent areas that might have promoted the formation of O3 in a more significant way.","Sci Total Environ","Collivignarelli, Maria Cristina","Abba, Alessandro","Bertanza, Giorgio","Pedrazzani, Roberta","Ricciardi, Paola","Carnevale Miino, Marco","32402928"],"abstract":["Based on the rapid spread of the CoViD-2019, a lockdown was declared in the whole Northern Italy by the Government. The application of increasingly rigorous containment measures allowed to reduce the impact of the CoViD-2019 pandemic on the Italian National Health System but at the same time these restriction measures gave also the opportunity to assess the effect of anthropogenic activities on air pollutants in an unprecedented way. This paper aims to study the impact of the partial and total lockdown (PL and TL, respectively) on air quality in the Metropolitan City of Milan. As results, the severe limitation of people movements following the PL and the subsequent TL determined a significant reduction of pollutants concentration mainly due to vehicular traffic (PM10, PM2.5, BC, benzene, CO, and NOx). The lockdown led to an appreciable drop in SO2 only in the city of Milan while it remained unchanged in the adjacent areas. Despite the significant decrease in NO2 in the TL, the O3 exhibited a significant increase, probably, due to the minor NO concentration. In Milan and SaA the increase was more accentuated, probably, due to the higher average concentrations of benzene in Milan than the adjacent areas that might have promoted the formation of O3 in a more significant way."],"journal":"Sci Total Environ","authors":["Collivignarelli, Maria Cristina","Abba, Alessandro","Bertanza, Giorgio","Pedrazzani, Roberta","Ricciardi, Paola","Carnevale Miino, Marco"],"date":"2020-05-14T11:00:00Z","year":2020,"_id":"32402928","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.scitotenv.2020.139280","keywords":["air monitoring","covid","coronavirus","ozone","pm(10)","sars-cov 2"],"locations":["Milan","Milan","Milan","Milan","Milan"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Prevention"],"weight":1,"_version_":1666714494997364736,"score":223.9401},{"pmid":32217835,"pmcid":"PMC7190990","title":"Clinical and immunological features of severe and moderate coronavirus disease 2019.","text":["Clinical and immunological features of severe and moderate coronavirus disease 2019.","BACKGROUNDSince December 2019, an outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, and is now becoming a global threat. We aimed to delineate and compare the immunological features of severe and moderate COVID-19.METHODSIn this retrospective study, the clinical and immunological characteristics of 21 patients (17 male and 4 female) with COVID-19 were analyzed. These patients were classified as severe (11 cases) and moderate (10 cases) according to the guidelines released by the National Health Commission of China.RESULTSThe median age of severe and moderate cases was 61.0 and 52.0 years, respectively. Common clinical manifestations included fever, cough, and fatigue. Compared with moderate cases, severe cases more frequently had dyspnea, lymphopenia, and hypoalbuminemia, with higher levels of alanine aminotransferase, lactate dehydrogenase, C-reactive protein, ferritin, and D-dimer as well as markedly higher levels of IL-2R, IL-6, IL-10, and TNF-alpha. Absolute numbers of T lymphocytes, CD4+ T cells, and CD8+ T cells decreased in nearly all the patients, and were markedly lower in severe cases (294.0, 177.5, and 89.0 x 106/L, respectively) than moderate cases (640.5, 381.5, and 254.0 x 106/L, respectively). The expression of IFN-gamma by CD4+ T cells tended to be lower in severe cases (14.1%) than in moderate cases (22.8%).CONCLUSIONThe SARS-CoV-2 infection may affect primarily T lymphocytes, particularly CD4+ and CD8+ T cells, resulting in a decrease in numbers as well as IFN-gamma production by CD4+ T cells. These potential immunological markers may be of importance because of their correlation with disease severity in COVID-19.TRIAL REGISTRATIONThis is a retrospective observational study without a trial registration number.FUNDINGThis work is funded by grants from Tongji Hospital for the Pilot Scheme Project, and partly supported by the Chinese National Thirteenth Five Years Project in Science and Technology for Infectious Disease (2017ZX10202201).","J Clin Invest","Chen, Guang","Wu, Di","Guo, Wei","Cao, Yong","Huang, Da","Wang, Hongwu","Wang, Tao","Zhang, Xiaoyun","Chen, Huilong","Yu, Haijing","Zhang, Xiaoping","Zhang, Minxia","Wu, Shiji","Song, Jianxin","Chen, Tao","Han, Meifang","Li, Shusheng","Luo, Xiaoping","Zhao, Jianping","Ning, Qin","32217835"],"abstract":["BACKGROUNDSince December 2019, an outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in Wuhan, and is now becoming a global threat. We aimed to delineate and compare the immunological features of severe and moderate COVID-19.METHODSIn this retrospective study, the clinical and immunological characteristics of 21 patients (17 male and 4 female) with COVID-19 were analyzed. These patients were classified as severe (11 cases) and moderate (10 cases) according to the guidelines released by the National Health Commission of China.RESULTSThe median age of severe and moderate cases was 61.0 and 52.0 years, respectively. Common clinical manifestations included fever, cough, and fatigue. Compared with moderate cases, severe cases more frequently had dyspnea, lymphopenia, and hypoalbuminemia, with higher levels of alanine aminotransferase, lactate dehydrogenase, C-reactive protein, ferritin, and D-dimer as well as markedly higher levels of IL-2R, IL-6, IL-10, and TNF-alpha. Absolute numbers of T lymphocytes, CD4+ T cells, and CD8+ T cells decreased in nearly all the patients, and were markedly lower in severe cases (294.0, 177.5, and 89.0 x 106/L, respectively) than moderate cases (640.5, 381.5, and 254.0 x 106/L, respectively). The expression of IFN-gamma by CD4+ T cells tended to be lower in severe cases (14.1%) than in moderate cases (22.8%).CONCLUSIONThe SARS-CoV-2 infection may affect primarily T lymphocytes, particularly CD4+ and CD8+ T cells, resulting in a decrease in numbers as well as IFN-gamma production by CD4+ T cells. These potential immunological markers may be of importance because of their correlation with disease severity in COVID-19.TRIAL REGISTRATIONThis is a retrospective observational study without a trial registration number.FUNDINGThis work is funded by grants from Tongji Hospital for the Pilot Scheme Project, and partly supported by the Chinese National Thirteenth Five Years Project in Science and Technology for Infectious Disease (2017ZX10202201)."],"journal":"J Clin Invest","authors":["Chen, Guang","Wu, Di","Guo, Wei","Cao, Yong","Huang, Da","Wang, Hongwu","Wang, Tao","Zhang, Xiaoyun","Chen, Huilong","Yu, Haijing","Zhang, Xiaoping","Zhang, Minxia","Wu, Shiji","Song, Jianxin","Chen, Tao","Han, Meifang","Li, Shusheng","Luo, Xiaoping","Zhao, Jianping","Ning, Qin"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32217835","source":"PubMed","week":"202013|Mar 23 - Mar 29","doi":"10.1172/JCI137244","keywords":["covid-19","cytokines","immunology","infectious disease","respiration","t cells"],"locations":["Wuhan","ferritin"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Mechanism"],"weight":1,"_version_":1666138490489798656,"score":215.44203},{"pmid":32479985,"pmcid":"PMC7256549","title":"Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.","text":["Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.","The lymphopenia exhibited in patients with COVID-19 has been associated with a worse prognosis in the development of the disease. To understand the factors associated with a worse evolution of COVID-19, we analyzed comorbidities, indicators of inflammation such as CRP and the ratio of neutrophils/lymphocytes, as well as the count of blood cells with T-lymphocyte subtypes in 172 hospitalized patients with COVID-19 pneumonia. Patients were grouped according to their needs for mechanical ventilation (ICU care) or not. Within the comorbidities studied, obesity was the only associated with greater severity and ICU admission. Both the percentage and the absolute number of neutrophils were higher in patients needing ICU care than non-ICU patients, whereas absolute lymphocyte count, and especially the percentage of lymphocytes, presented a deep decline in critical patients. There was no difference between the two groups of patients for CD4 T-lymphocytes, neither in percentage of lymphocyte nor in absolute number, however for CD8 T-cells the differences were significant for both parameters which were in decline in ICU patients. There was a firm correlation between the highest values of inflammation indicators with the decrease in percentage of CD8 T-lymphocytes. This effect was not seen with CD4 cells. Obesity together with lymphopenia, especially whether preferentially affects to CD8 T- lymphocytes, are factors that can predict a poor prognosis in patients with COVID-19.","Clin Immunol","Urra, J M","Cabrera, C M","Porras, L","Rodenas, I","32479985"],"abstract":["The lymphopenia exhibited in patients with COVID-19 has been associated with a worse prognosis in the development of the disease. To understand the factors associated with a worse evolution of COVID-19, we analyzed comorbidities, indicators of inflammation such as CRP and the ratio of neutrophils/lymphocytes, as well as the count of blood cells with T-lymphocyte subtypes in 172 hospitalized patients with COVID-19 pneumonia. Patients were grouped according to their needs for mechanical ventilation (ICU care) or not. Within the comorbidities studied, obesity was the only associated with greater severity and ICU admission. Both the percentage and the absolute number of neutrophils were higher in patients needing ICU care than non-ICU patients, whereas absolute lymphocyte count, and especially the percentage of lymphocytes, presented a deep decline in critical patients. There was no difference between the two groups of patients for CD4 T-lymphocytes, neither in percentage of lymphocyte nor in absolute number, however for CD8 T-cells the differences were significant for both parameters which were in decline in ICU patients. There was a firm correlation between the highest values of inflammation indicators with the decrease in percentage of CD8 T-lymphocytes. This effect was not seen with CD4 cells. Obesity together with lymphopenia, especially whether preferentially affects to CD8 T- lymphocytes, are factors that can predict a poor prognosis in patients with COVID-19."],"journal":"Clin Immunol","authors":["Urra, J M","Cabrera, C M","Porras, L","Rodenas, I"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32479985","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.clim.2020.108486","topics":["Treatment","Mechanism","Diagnosis"],"weight":1,"_version_":1668532089484476416,"score":195.0986},{"pmid":32227123,"pmcid":"PMC7184346","title":"Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia.","text":["Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia.","BACKGROUND: Since December 2019, novel coronavirus (SARS-CoV-2)-infected pneumonia (COVID-19) occurred in Wuhan, and rapidly spread throughout China. We aimed to clarify the characteristics and clinical significance of peripheral lymphocyte subset alteration in COVID-19. METHODS: The levels of peripheral lymphocyte subsets were measured by flow cytometry in 60 hospitalized COVID-19 patients before and after treatment, and their association with clinical characteristics and treatment efficacy was analyzed. RESULTS: Total lymphocytes, CD4+ T cells, CD8+ T cells, B cells and natural killer (NK) cells decreased in COVID-19 patients, and severe cases had a lower level than mild cases. The subsets showed a significant association with the inflammatory status in COVID-19, especially CD8+ T cells and CD4+/CD8+ ratio. After treatment, 37 patients (67%) reached clinical response, with an increase of CD8+ T cells and B cells. No significant change of any subset was detected in non-response cases. In multivariate analysis, post-treatment decrease of CD8+ T cells and B cells and increase of CD4+/CD8+ ratio were indicated as independent predictors for poor efficacy. CONCLUSIONS: Peripheral lymphocyte subset alteration was associated with the clinical characteristics and treatment efficacy of COVID-19. CD8+ T cells tended to be an independent predictor for COVID-19 severity and treatment efficacy.","J Infect Dis","Wang, Fan","Nie, Jiayan","Wang, Haizhou","Zhao, Qiu","Xiong, Yong","Deng, Liping","Song, Shihui","Ma, Zhiyong","Mo, Pingzheng","Zhang, Yongxi","32227123"],"abstract":["BACKGROUND: Since December 2019, novel coronavirus (SARS-CoV-2)-infected pneumonia (COVID-19) occurred in Wuhan, and rapidly spread throughout China. We aimed to clarify the characteristics and clinical significance of peripheral lymphocyte subset alteration in COVID-19. METHODS: The levels of peripheral lymphocyte subsets were measured by flow cytometry in 60 hospitalized COVID-19 patients before and after treatment, and their association with clinical characteristics and treatment efficacy was analyzed. RESULTS: Total lymphocytes, CD4+ T cells, CD8+ T cells, B cells and natural killer (NK) cells decreased in COVID-19 patients, and severe cases had a lower level than mild cases. The subsets showed a significant association with the inflammatory status in COVID-19, especially CD8+ T cells and CD4+/CD8+ ratio. After treatment, 37 patients (67%) reached clinical response, with an increase of CD8+ T cells and B cells. No significant change of any subset was detected in non-response cases. In multivariate analysis, post-treatment decrease of CD8+ T cells and B cells and increase of CD4+/CD8+ ratio were indicated as independent predictors for poor efficacy. CONCLUSIONS: Peripheral lymphocyte subset alteration was associated with the clinical characteristics and treatment efficacy of COVID-19. CD8+ T cells tended to be an independent predictor for COVID-19 severity and treatment efficacy."],"journal":"J Infect Dis","authors":["Wang, Fan","Nie, Jiayan","Wang, Haizhou","Zhao, Qiu","Xiong, Yong","Deng, Liping","Song, Shihui","Ma, Zhiyong","Mo, Pingzheng","Zhang, Yongxi"],"date":"2020-04-01T11:00:00Z","year":2020,"_id":"32227123","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1093/infdis/jiaa150","keywords":["covid-19","lymphocyte subset","pneumonia"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138492442247168,"score":177.56474}]}